Proffered paper session - Genitourinary tumours, prostate
Proffered paper session - Genitourinary tumours, prostate - Invited Discussant LBA30
Date
19 Oct 2018Session
Proffered paper session - Genitourinary tumours, prostatePresenters
Daniel HeinrichAuthors
D. HeinrichAuthor affiliations
- Department Of Oncology, Akershus University Hospital, 1478 - Lørenskog/NO
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
2933 - Updated results of GETUG-12, a phase 3 trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up.
Presenter: Karim Fizazi
Session: Proffered paper session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Proffered paper session - Genitourinary tumours, prostate - Invited Discussant 791O
Presenter: Eleni Efstathiou
Session: Proffered paper session - Genitourinary tumours, prostate
Resources:
Slides
Webcast
2672 - ERA 223: A phase 3 trial of radium-223 (Ra-223) in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve patients (pts) with bone-predominant metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Matthew Smith
Session: Proffered paper session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
1576 - A Randomized Phase 2 Study of Cabazitaxel (CAB) vs (ABI) Abiraterone or (ENZ) Enzalutamide in Poor Prognosis Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Presenter: Kim Chi
Session: Proffered paper session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Proffered paper session - Genitourinary tumours, prostate - Invited Discussant 792O
Presenter: Stéphane Oudard
Session: Proffered paper session - Genitourinary tumours, prostate
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.